Infinity is an infectious disease laboratory based out of Northern Texas specializing in molecular diagnostics. The acquisition will provide Patients Choice with a foothold in the southern United States, according to an Oct. 18 Patients Choice news release provided to Becker’s.
Patients Choice will begin running tests in the newly acquired laboratory in the coming weeks.
“Having already performed laboratory services for Texans for many years, we are looking forward to teaming up with the Texas healthcare community as a local laboratory,” Patients Choice President Brad Moss said. “We have a proud history of assisting providers in accelerating their decision-making process for treatment, providing the fastest turnaround times in the lab industry, and working with some of the leading health systems and providers in the nation. Our plan is to introduce our complete suite of services to area providers so that they can work with one laboratory to service all their diagnostics needs.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
